{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:41:09Z","timestamp":1781649669939,"version":"3.54.5"},"reference-count":60,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"unspecified","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008982","name":"Qatar National Research Fund","doi-asserted-by":"publisher","award":["NPRP-74613117"],"award-info":[{"award-number":["NPRP-74613117"]}],"id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2021,6,30]]},"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Decreased insulin sensitivity occurs early in type 2 diabetes (T2D). T2D is highly prevalent in the Middle East and North Africa regions. This study assessed the variations in insulin sensitivity in normal apparently healthy subjects and the levels of adiponectin, adipsin and inflammatory markers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>A total of 60 participants (aged 18\u201345, body mass index &lt;28) with a normal oral glucose tolerance test (OGTT) completed hyperinsulinemic-euglycemic clamp (40 mU\/m<jats:sup>2<\/jats:sup>\/min) and body composition test by dual-energy X-ray absorptiometry scan. Blood samples were assayed for glucose, insulin, C peptide, inflammatory markers, oxidative stress markers, adiponectin and adipsin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The subjects showed wide variations in the whole-body glucose disposal rate (M value) from 2 to 20 mg\/kg\/min and were divided into three groups: most responsive (M&gt;12\u2009mg\/kg\/min, n=17), least responsive (M\u22646\u2009mg\/kg\/min, n=14) and intermediate responsive (M=6.1\u201312\u2009mg\/kg\/min, n=29). Insulin and C peptide responses to OGTT were highest among the least insulin sensitive group. Triglycerides, cholesterol, alanine transaminase (ALT) and albumin levels were higher in the least responsive group compared with the other groups. Among the inflammatory markers, C reactive protein (CRP) was highest in the least sensitivity group compared with the other groups; however, there were no differences in the level of soluble receptor for advanced glycation end products and Tumor Necrosis Factor Receptor Superfamily 1B (TNFRS1B). Plasma levels of insulin sensitivity markers, adiponectin and adipsin, and oxidative stress markers, oxidized low-density lipoprotein, total antioxidant capacity and glutathione peroxidase 1, were similar between the groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A wide range in insulin sensitivity and significant differences in triglycerides, cholesterol, ALT and CRP concentrations were observed despite the fact that the study subjects were homogenous in terms of age, gender and ethnic background, and all had normal screening comprehensive chemistry and normal glucose response to OGTT. The striking differences in insulin sensitivity reflect differences in genetic predisposition and\/or environmental exposure. The low insulin sensitivity status associated with increased insulin level may represent an early stage of metabolic abnormality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2020-002039","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T11:46:08Z","timestamp":1637063168000},"page":"e002039","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Insulin sensitivity variations in apparently healthy Arab male subjects: correlation with insulin and C peptide"],"prefix":"10.1136","volume":"9","author":[{"given":"Noor","family":"Suleiman","sequence":"first","affiliation":[{"name":"Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meis","family":"Alkasem","sequence":"additional","affiliation":[{"name":"Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa","family":"Hassoun","sequence":"additional","affiliation":[{"name":"Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahem","family":"Abdalhakam","sequence":"additional","affiliation":[{"name":"Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilham","family":"Bettahi","sequence":"additional","affiliation":[{"name":"Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar"},{"name":"Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayaz","family":"Mir","sequence":"additional","affiliation":[{"name":"Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar"},{"name":"Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9765-9818","authenticated-orcid":false,"given":"Manjunath","family":"Ramanjaneya","sequence":"additional","affiliation":[{"name":"Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar"},{"name":"Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayakumar","family":"Jerobin","sequence":"additional","affiliation":[{"name":"Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar"},{"name":"Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Iskandarani","sequence":"additional","affiliation":[{"name":"Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar"},{"name":"Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tareq A","family":"Samra","sequence":"additional","affiliation":[{"name":"Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar"},{"name":"Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem","family":"Chandra","sequence":"additional","affiliation":[{"name":"Medical Research Center, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Skarulis","sequence":"additional","affiliation":[{"name":"Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Badi","family":"Abou-Samra","sequence":"additional","affiliation":[{"name":"Qatar Metabolic Institute, Hamad Medical Corporation, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"2025073111515299000_9.2.e002039.1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.41.11.1473"},{"key":"2025073111515299000_9.2.e002039.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292703"},{"key":"2025073111515299000_9.2.e002039.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81125-3"},{"key":"2025073111515299000_9.2.e002039.4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10761"},{"key":"2025073111515299000_9.2.e002039.5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29024"},{"key":"2025073111515299000_9.2.e002039.6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29069"},{"key":"2025073111515299000_9.2.e002039.7","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0203"},{"key":"2025073111515299000_9.2.e002039.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1684-1"},{"key":"2025073111515299000_9.2.e002039.9","doi-asserted-by":"publisher","DOI":"10.2337\/diab.15.9.623"},{"key":"2025073111515299000_9.2.e002039.10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.2.471"},{"key":"2025073111515299000_9.2.e002039.11","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.11.2572"},{"key":"2025073111515299000_9.2.e002039.12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI88880"},{"key":"2025073111515299000_9.2.e002039.13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114142"},{"key":"2025073111515299000_9.2.e002039.14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.7.2329"},{"key":"2025073111515299000_9.2.e002039.15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10842"},{"key":"2025073111515299000_9.2.e002039.16","doi-asserted-by":"publisher","DOI":"10.1038\/nature05482"},{"key":"2025073111515299000_9.2.e002039.17","first-page":"E551","article-title":"Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity","volume":"277","author":"Albu","year":"1999","journal-title":"Am J Physiol"},{"key":"2025073111515299000_9.2.e002039.18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4158\/EP.11.4.234","article-title":"Free fatty acids, insulin resistance, and corrected QT intervals in morbid obesity: effect of weight loss during 6 months with differing dietary interventions","volume":"11","author":"Seshadri","year":"2005","journal-title":"Endocr Pract"},{"key":"2025073111515299000_9.2.e002039.19","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2274"},{"key":"2025073111515299000_9.2.e002039.20","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050046"},{"key":"2025073111515299000_9.2.e002039.21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1172\/JCI117715","article-title":"Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus","volume":"95","author":"Vaag","year":"1995","journal-title":"J Clin Invest"},{"key":"2025073111515299000_9.2.e002039.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031314"},{"key":"2025073111515299000_9.2.e002039.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2009.02.003"},{"key":"2025073111515299000_9.2.e002039.24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.dsx.2014.09.005","article-title":"Burden of diabetes mellitus attributable to demographic levels in Qatar: an emerging public health problem","volume":"8","author":"Bener","year":"2014","journal-title":"Diabetes Metab Syndr"},{"key":"2025073111515299000_9.2.e002039.25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-0042-103683","article-title":"Predictions burden of diabetes and economics cost: contributing risk factors of changing disease prevalence and its pandemic impact to Qatar","volume":"124","author":"Bener","year":"2016","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2025073111515299000_9.2.e002039.26","article-title":"Public awareness and perceptions about diabetes in the state of Qatar","volume":"10","author":"Al-Thani","year":"2018","journal-title":"Cureus"},{"key":"2025073111515299000_9.2.e002039.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201247","article-title":"Prevalence of newly detected diabetes in pregnancy in Qatar, using universal screening","volume":"13","author":"Bashir","year":"2018","journal-title":"PLoS One"},{"key":"2025073111515299000_9.2.e002039.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023612"},{"key":"2025073111515299000_9.2.e002039.29","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1979.237.3.E214"},{"key":"2025073111515299000_9.2.e002039.30","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.9.2796"},{"key":"2025073111515299000_9.2.e002039.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.03.016"},{"key":"2025073111515299000_9.2.e002039.32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21496"},{"key":"2025073111515299000_9.2.e002039.33","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.6.667"},{"key":"2025073111515299000_9.2.e002039.34","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.15.3.318"},{"key":"2025073111515299000_9.2.e002039.35","doi-asserted-by":"publisher","DOI":"10.2337\/diab.42.11.1663"},{"key":"2025073111515299000_9.2.e002039.36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29126"},{"key":"2025073111515299000_9.2.e002039.37","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.5.1930"},{"key":"2025073111515299000_9.2.e002039.38","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.2147\/DMSO.S253967","article-title":"Plasma adipsin as a biomarker and its implication in type 2 diabetes mellitus","volume":"13","author":"Tafere","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2025073111515299000_9.2.e002039.39","doi-asserted-by":"publisher","DOI":"10.1385\/IR:30:3:261"},{"key":"2025073111515299000_9.2.e002039.40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1758-5996-2-30","article-title":"Association between insulin resistance and C-reactive protein among Peruvian adults","volume":"2","author":"Gelaye","year":"2010","journal-title":"Diabetol Metab Syndr"},{"key":"2025073111515299000_9.2.e002039.41","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000065636.15310.9C"},{"key":"2025073111515299000_9.2.e002039.42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.5551\/jat.869","article-title":"High-sensitivity CRP reflects insulin resistance in smokers","volume":"16","author":"Hanyu","year":"2009","journal-title":"J Atheroscler Thromb"},{"key":"2025073111515299000_9.2.e002039.43","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-0034-1376990","article-title":"Dash diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial","volume":"47","author":"Asemi","year":"2015","journal-title":"Horm Metab Res"},{"key":"2025073111515299000_9.2.e002039.44","doi-asserted-by":"publisher","DOI":"10.1159\/000081973"},{"key":"2025073111515299000_9.2.e002039.45","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3109\/09513590.2013.824962","article-title":"The relationship of urotensin II with insulin resistance and hs-CRP in patients having PCOS","volume":"29","author":"Yilmaz","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"2025073111515299000_9.2.e002039.46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050155"},{"key":"2025073111515299000_9.2.e002039.47","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1210\/jc.2019-00987","article-title":"Oxidative stress in response to saturated fat ingestion is linked to insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"104","author":"Gonz\u00e1lez","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2025073111515299000_9.2.e002039.48","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01833"},{"key":"2025073111515299000_9.2.e002039.49","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20160503C"},{"key":"2025073111515299000_9.2.e002039.50","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/MEG.0000000000001138","article-title":"Povital role of platelet count in platelet-lymphocyte count used in distinguishing patients with significant liver fibrosis and insulin resistance","volume":"30","author":"Ozcelik","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025073111515299000_9.2.e002039.51","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1089\/met.2018.0016","article-title":"Relationship between platelet count and insulin resistance in Korean adolescents: a nationwide population-based study","volume":"16","author":"Park","year":"2018","journal-title":"Metab Syndr Relat Disord"},{"key":"2025073111515299000_9.2.e002039.52","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/dme.12835","article-title":"Discriminatory value of alanine aminotransferase for diabetes prediction: the insulin resistance atherosclerosis study","volume":"33","author":"Lorenzo","year":"2016","journal-title":"Diabet Med"},{"key":"2025073111515299000_9.2.e002039.53","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0086"},{"key":"2025073111515299000_9.2.e002039.54","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00125-012-2826-4","article-title":"The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the insulin resistance atherosclerosis study","volume":"56","author":"Lorenzo","year":"2013","journal-title":"Diabetologia"},{"key":"2025073111515299000_9.2.e002039.55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2005.01502.x"},{"key":"2025073111515299000_9.2.e002039.56","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006770","article-title":"Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy","volume":"96","author":"Martin-Rodriguez","year":"2017","journal-title":"Medicine"},{"key":"2025073111515299000_9.2.e002039.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2012.02.011"},{"key":"2025073111515299000_9.2.e002039.58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3803\/EnM.2013.28.1.26","article-title":"Association between serum albumin, insulin resistance, and incident diabetes in nondiabetic subjects","volume":"28","author":"Bae","year":"2013","journal-title":"Endocrinol Metab"},{"key":"2025073111515299000_9.2.e002039.59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176209","article-title":"Increase in serum albumin concentration is associated with prediabetes development and progression to overt diabetes independently of metabolic syndrome","volume":"12","author":"Jun","year":"2017","journal-title":"PLoS One"},{"key":"2025073111515299000_9.2.e002039.60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijge.2018.05.007","article-title":"The relationships between hemoglobin and diabetes factors (insulin resistance, glucose effectiveness, first- and second-phase insulin secretion) in old Chinese","volume":"12","author":"Chen","year":"2018","journal-title":"Int J Gerontol"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2020-002039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T18:52:03Z","timestamp":1753987923000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2020-002039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,11,16]]},"published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1136\/bmjdrc-2020-002039"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2020-002039","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}